AUVEN THERAPEUTICS: all contributions
2023–2024 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to AUVEN THERAPEUTICS| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 281 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | ACTBLUEC00401224 | 2023-08-29 | $50 | Not reported | EARMARKED FOR JEFFRIES FOR CONGRESS (C00503052)Filing 1752852FEC filing ↗ |
| 282 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | DCCCC00000935 | 2024-09-18 | $50 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 09/18/2024Filing 1842774 · amendedFEC filing ↗ |
| 283 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | ACTBLUEC00401224 | 2023-05-26 | $50 | Primary (P) | EARMARKED FOR STOP REPUBLICANS (C00633404)Filing 1720554FEC filing ↗ |
| 284 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | ACTBLUEC00401224 | 2023-10-04 | $50 | Not reported | EARMARKED FOR PROGRESSIVE TAKEOVER (C00659599)Filing 1752852FEC filing ↗ |
| 285 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | ACTBLUEC00401224 | 2023-05-26 | $50 | Primary (P) | EARMARKED FOR STOP REPUBLICANS (C00633404)Filing 1720554FEC filing ↗ |
| 286 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | ACTBLUEC00401224 | 2023-02-25 | $50 | Primary (P) | EARMARKED FOR VIRGIN ISLANDS FOR PLASKETT (C00528182)Filing 1720554FEC filing ↗ |
| 287 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | STOP REPUBLICANSC00633404 | 2023-07-07 | $63 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1745206FEC filing ↗ |
| 288 | CORR, PETER BST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | DCCCC00000935 | 2024-10-08 | $75 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 10/08/2024Filing 1845540 · amendedFEC filing ↗ |
| 289 | CORR, PETER BST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | DCCCC00000935 | 2024-10-08 | $75 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 10/08/2024Filing 1845540 · amendedFEC filing ↗ |
| 290 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | DCCCC00000935 | 2024-09-19 | $75 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 09/19/2024Filing 1842774 · amendedFEC filing ↗ |
| 291 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | DCCCC00000935 | 2023-10-29 | $75 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 10/29/2023Filing 1754920 · amendedFEC filing ↗ |
| 292 | CORR, PETER BST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | DCCCC00000935 | 2024-10-08 | $75 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 10/08/2024Filing 1845540 · amendedFEC filing ↗ |
| 293 | CORR, PETER BST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | DCCCC00000935 | 2024-10-10 | $75 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 10/10/2024Filing 1845540 · amendedFEC filing ↗ |
| 294 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | DCCCC00000935 | 2024-09-04 | $75 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 09/04/2024Filing 1842774 · amendedFEC filing ↗ |
| 295 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-08 | $78 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 296 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-10-08 | $78 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875039 · amendedFEC filing ↗ |
| 297 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2023-12-16 | $78 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875007 · amendedFEC filing ↗ |
| 298 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-08-31 | $78 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875031 · amendedFEC filing ↗ |
| 299 | CORR, PETER B.ST THOMASVI00802 | DRUG DEVELOPER AND INVESTORAUVEN THERAPEUTICS | EQUALITY PACC00550970 | 2024-09-20 | $78 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1875036 · amendedFEC filing ↗ |
| 300 | CORR, PETERST THOMASVI00802 | MANAGING GENERAL PARTNERAUVEN THERAPEUTICS | ACTBLUEC00401224 | 2023-02-20 | $100 | Primary (P) | EARMARKED FOR VIRGIN ISLANDS FOR PLASKETT (C00528182)Filing 1720554FEC filing ↗ |
This small employer group is read directly through the employer index, then sorted and paginated. Only the latest version within matching employer records is shown; amendments that change the employer may affect this grouping. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.